Good evening :)
Place Order
Add to Watchlist

Bajaj Healthcare Ltd

BAJAJHCARE

Bajaj Healthcare Ltd

BAJAJHCARE
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,065 cr, stock is ranked 1,387
High RiskStock is 3.69x as volatile as Nifty
372.450.00% (+0.00)
372.450.00% (+0.00)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,065 cr, stock is ranked 1,387
High RiskStock is 3.69x as volatile as Nifty

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,065 cr, stock is ranked 1,387
High RiskStock is 3.69x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
-12.722.900.26%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
45.196.090.52%

Forecast & Ratings

Detailed Forecast 
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Bajaj Healthcare Limited is an India-based pharmaceutical company. The Company is engaged in the manufacturing of bulk drugs and pharmaceutical products. The Company's segments include manufacturing of Bulk Drugs, and Formulation and sale of medicines.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Lower than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 5.37%, vs industry avg of 8.96%

Decreasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 0.16% to 0.13%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue223.22233.04329.18371.14416.54663.89681.33674.89482.10484.18
Raw Materialssubtract128.77131.50215.43245.33268.32377.19409.91428.44510.95513.02
Power & Fuel Costsubtract14.1216.7919.8121.8324.2424.9631.8341.46
Employee Costsubtract16.9319.5721.6524.6228.1834.5541.1147.84
Selling & Administrative Expensessubtract6.015.685.687.318.0012.9114.8615.73
Operating & Other expensessubtract26.9626.2825.1028.1632.9871.0063.5232.86
Depreciation/Amortizationsubtract9.2911.3511.0811.4112.1216.1217.6427.3627.6227.62
Interest & Other Itemssubtract7.648.207.738.326.638.3412.7822.9929.6829.67
Taxes & Other Itemssubtract5.295.877.507.8610.8235.7118.3015.19-2.35-2.35
EPS2.281.432.752.954.5715.0617.2415.59-30.36-30.36
DPS0.000.000.250.000.001.381.501.001.001.00
Payout ratio0.000.000.090.000.000.090.090.06-0.03

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2021

Annual report

PDF

Investor Presentation

Aug 18PDF
FY 2022

Annual report

PDF

Investor Presentation

Jun 27PDF
 

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Bajaj Healthcare Ltd-12.712.900.26%
Sun Pharmaceutical Industries Ltd39.615.650.85%
Cipla Ltd29.735.170.86%
Zydus Lifesciences Ltd30.975.410.25%

Price Comparison

Compare BAJAJHCARE with any stock or ETF
Compare BAJAJHCARE with any stock or ETF
BAJAJHCARE
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Increased Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has increased by 1.88%

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding67.73%0.00%0.43%0.53%31.30%

Jun 2023

Sep 2023

Dec 2023

Mar 2024

Shareholding History

Dec '22MarJunSepDec '23Mar0.94%0.78%0.69%0.66%0.74%0.53%

Insider Trades & Bulk Deals

Loading...

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateSep 22, 2023

Final
Final | Div/Share: ₹1.00

Dividend/Share

1.00

Ex DateEx Date

Sep 22, 2023

Cash Dividend

Ex DateEx DateSep 22, 2022

Final
Final | Div/Share: ₹1.50

Dividend/Share

1.50

Ex DateEx Date

Sep 22, 2022

Cash Dividend

Ex DateEx DateSep 28, 2021

Final
Final | Div/Share: ₹0.50

Dividend/Share

0.50

Ex DateEx Date

Sep 28, 2021

Cash Dividend

Ex DateEx DateSep 28, 2021

Final
Final | Div/Share: ₹0.50

Dividend/Share

0.50

Ex DateEx Date

Sep 28, 2021

Cash Dividend

Ex DateEx DateSep 28, 2021

Special
Special | Div/Share: ₹0.50

Dividend/Share

0.50

Ex DateEx Date

Sep 28, 2021